These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 34170791)

  • 21. Care for children with atopic dermatitis in the Netherlands during the COVID-19 pandemic: Lessons from the first wave and implications for the future.
    Ragamin A; de Wijs LEM; Hijnen DJ; Arends NJT; Schuttelaar MLA; Pasmans SGMA; Bronner MB
    J Dermatol; 2021 Dec; 48(12):1863-1870. PubMed ID: 34459024
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial.
    Zhu FC; Li YH; Guan XH; Hou LH; Wang WJ; Li JX; Wu SP; Wang BS; Wang Z; Wang L; Jia SY; Jiang HD; Wang L; Jiang T; Hu Y; Gou JB; Xu SB; Xu JJ; Wang XW; Wang W; Chen W
    Lancet; 2020 Jun; 395(10240):1845-1854. PubMed ID: 32450106
    [TBL] [Abstract][Full Text] [Related]  

  • 23. COVID-19 vaccine safety and efficacy in patients with immune-mediated inflammatory disease: Review of available evidence.
    Wack S; Patton T; Ferris LK
    J Am Acad Dermatol; 2021 Nov; 85(5):1274-1284. PubMed ID: 34363909
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A case series of live attenuated vaccine administration in dupilumab-treated children with atopic dermatitis.
    Siegfried EC; Wine Lee L; Spergel JM; Prescilla R; Uppal S; Coleman A; Bansal A; Cyr SL; Shumel B
    Pediatr Dermatol; 2024; 41(2):204-209. PubMed ID: 38308453
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of the COVID-19 Pandemic on Atopic Dermatitis Patients.
    Sieniawska J; Lesiak A; Ciążyński K; Narbutt J; Ciążyńska M
    Int J Environ Res Public Health; 2022 Feb; 19(3):. PubMed ID: 35162757
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Technical guidelines for seasonal influenza vaccination in China (2022-2023)].
    National Immunization Advisory Committee (NIAC) Technical Working Group (TWG), Influenza Vaccination TWG
    Zhonghua Liu Xing Bing Xue Za Zhi; 2022 Oct; 43(10):1515-1544. PubMed ID: 36456484
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Current guidelines for the evaluation and management of atopic dermatitis: A comparison of the Joint Task Force Practice Parameter and American Academy of Dermatology guidelines.
    Eichenfield LF; Ahluwalia J; Waldman A; Borok J; Udkoff J; Boguniewicz M
    J Allergy Clin Immunol; 2017 Apr; 139(4S):S49-S57. PubMed ID: 28390477
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Induction, treatment and prevention of eczema vaccinatum in atopic dermatitis mouse models.
    Achdout H; Lustig S; Israely T; Erez N; Politi B; Tamir H; Israeli O; Waner T; Melamed S; Paran N
    Vaccine; 2017 Jul; 35(33):4245-4254. PubMed ID: 28625523
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Current scenario of COVID-19 vaccinations and immune response along with antibody titer in vaccinated inhabitants of different countries.
    Hussain A; Rafeeq H; Asif HM; Shabbir S; Bilal M; Mulla SI; Franco M; Iqbal HMN
    Int Immunopharmacol; 2021 Oct; 99():108050. PubMed ID: 34426120
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety and immunogenicity of the SARS-CoV-2 ARCoV mRNA vaccine in Chinese adults: a randomised, double-blind, placebo-controlled, phase 1 trial.
    Chen GL; Li XF; Dai XH; Li N; Cheng ML; Huang Z; Shen J; Ge YH; Shen ZW; Deng YQ; Yang SY; Zhao H; Zhang NN; Zhang YF; Wei L; Wu KQ; Zhu MF; Peng CG; Jiang Q; Cao SC; Li YH; Zhao DH; Wu XH; Ni L; Shen HH; Dong C; Ying B; Sheng GP; Qin CF; Gao HN; Li LJ
    Lancet Microbe; 2022 Mar; 3(3):e193-e202. PubMed ID: 35098177
    [TBL] [Abstract][Full Text] [Related]  

  • 31. COVID-19 vaccination of patients with allergies and type-2 inflammation with concurrent antibody therapy (biologicals) - A Position Paper of the German Society of Allergology and Clinical Immunology (DGAKI) and the German Society for Applied Allergology (AeDA).
    Pfaar O; Klimek L; Hamelmann E; Kleine-Tebbe J; Taube C; Wagenmann M; Werfel T; Brehler R; Novak N; Mülleneisen N; Becker S; Worm M
    Allergol Select; 2021; 5():140-147. PubMed ID: 33842829
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protocol for SARS-CoV-2 post-vaccine surveillance study in Australian adults and children with cancer: an observational study of safety and serological and immunological response to SARS-CoV-2 vaccination (SerOzNET).
    Body A; Ahern E; Lal L; Gillett K; Abdulla H; Opat S; O'Brien T; Downie P; Turville S; Munier CML; Smith C; MacIntyre CR; Segelov E
    BMC Infect Dis; 2022 Jan; 22(1):70. PubMed ID: 35057745
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protective Efficacy of Rhesus Adenovirus COVID-19 Vaccines against Mouse-Adapted SARS-CoV-2.
    Tostanoski LH; Gralinski LE; Martinez DR; Schaefer A; Mahrokhian SH; Li Z; Nampanya F; Wan H; Yu J; Chang A; Liu J; McMahan K; Ventura JD; Dinnon KH; Leist SR; Baric RS; Barouch DH
    J Virol; 2021 Nov; 95(23):e0097421. PubMed ID: 34523968
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Autoimmune and inflammatory thyroid diseases following vaccination with SARS-CoV-2 vaccines: from etiopathogenesis to clinical management.
    Caron P
    Endocrine; 2022 Dec; 78(3):406-417. PubMed ID: 35763241
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Using BCG vaccine to enhance non-specific protection of health care workers during the COVID-19 pandemic: A structured summary of a study protocol for a randomised controlled trial in Denmark.
    Madsen AMR; Schaltz-Buchholzer F; Benfield T; Bjerregaard-Andersen M; Dalgaard LS; Dam C; Ditlev SB; Faizi G; Johansen IS; Kofoed PE; Kristensen GS; Loekkegaard ECL; Mogensen CB; Mohamed L; Ostenfeld A; Oedegaard ES; Soerensen MK; Wejse C; Jensen AKG; Nielsen S; Krause TG; Netea MG; Aaby P; Benn CS
    Trials; 2020 Sep; 21(1):799. PubMed ID: 32943115
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Live-attenuated vaccine sCPD9 elicits superior mucosal and systemic immunity to SARS-CoV-2 variants in hamsters.
    Nouailles G; Adler JM; Pennitz P; Peidli S; Teixeira Alves LG; Baumgardt M; Bushe J; Voss A; Langenhagen A; Langner C; Martin Vidal R; Pott F; Kazmierski J; Ebenig A; Lange MV; Mühlebach MD; Goekeri C; Simmons S; Xing N; Abdelgawad A; Herwig S; Cichon G; Niemeyer D; Drosten C; Goffinet C; Landthaler M; Blüthgen N; Wu H; Witzenrath M; Gruber AD; Praktiknjo SD; Osterrieder N; Wyler E; Kunec D; Trimpert J
    Nat Microbiol; 2023 May; 8(5):860-874. PubMed ID: 37012419
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The corona pandemic and multiple sclerosis: vaccinations and their implications for patients-Part 2: vaccine technologies].
    Monschein T; Zrzavy T; Löbermann M; Winkelmann A; Berger T; Rommer P; Hartung HP; Zettl UK
    Nervenarzt; 2021 Dec; 92(12):1283-1292. PubMed ID: 34232358
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Current epidemiology of atopic dermatitis in south-eastern Nigeria.
    Nnoruka EN
    Int J Dermatol; 2004 Oct; 43(10):739-44. PubMed ID: 15485531
    [TBL] [Abstract][Full Text] [Related]  

  • 39. COVID-19 Vaccine: A comprehensive status report.
    Kaur SP; Gupta V
    Virus Res; 2020 Oct; 288():198114. PubMed ID: 32800805
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recommendations for Vaccination in Children with Atopic Dermatitis Treated with Dupilumab: A Consensus Meeting, 2020.
    Martinez-Cabriales SA; Kirchhof MG; Constantinescu CM; Murguia-Favela L; Ramien ML
    Am J Clin Dermatol; 2021 Jul; 22(4):443-455. PubMed ID: 34076879
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.